Automation-ready blowdown evaporator available from Porvair Sciences
The Ultravap Levante will appeal to the budget-conscious laboratory who may wish to automate their sample dry-down bottleneck in the future.
The Ultravap Levante from Porvair Sciences is a next generation nitrogen blowdown evaporator designed to meet the needs of the modern automated laboratory.
The Ultravap Levante comes with an RS232 connection and a remote command set enabling it to connect to and be operated from most commercially available robotic liquid handling systems. Porvair have positioned this automation-ready microplate evaporator to appeal to the budget-conscious laboratory who may wish to automate their sample dry-down bottleneck in the future.
With the Ultravap Levante users get full-colour touchscreen graphic displays, an integrated auto-ranging power supply and built-in solvent fume venting. Combined with real-time run displays showing actual gas temperature, gas flow rate and stage height the Ultravap Levante puts users in full control of their evaporation protocols. Offering multi-step ramped programming with full alphanumeric program naming, the Levante offers the capability to automatically handle even complex evaporation protocols effortlessly.
Designed around a standard ANSI/SLAS plate 'nest' to accept most microplate formats and tube racks, the Ultravap Levante can accommodate tubes up to 80mm in height in a variety of configurations to allow the use of 2 Dram vials, 1.5 mL HPLC vials, bar-coded tubes in racks and many other common formats. Evaporator heads are made to match these formats in 24-, 48-, 96- and 384-well configurations. The unique Porvair 96-well spiral needle head, which creates a vortex in certain plates to speed up evaporation, can also be used on the Ultravap Levante.
The Ultravap Levante can be operated from an in-house supply of nitrogen/clean dry air or from a gas cylinder. The blowdown technique employed by the Ultravap Levante has been widely adopted by labs worldwide for removing chromatography solvents such as dichloromethane, acetonitrile, methanol and hexane.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance